Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Hsiang Lin

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|February 4, 2016
Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasionI-Hsiao Chung, Tzu-I Wu, Chia-Jung Liao, et al.
American Journal of Cancer Research|August 8, 2024
CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progressionHsiang-Cheng Chi, Yang-Hsiang Lin, Yuh-Harn Wu, et al.
International Journal of Molecular Sciences|June 21, 2016
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerMing-Ming Tsai, Chia-Siu Wang, Chung-Ying Tsai, et al.
International Journal of Molecular Sciences|January 21, 2023
A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular CarcinomaChih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, et al.
Cells|April 17, 2020
Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver CancerPo-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, et al.
Scientific Reports|November 3, 2017
Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214Po-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, et al.
Theranostics|June 1, 2019
Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancerChing-Ying Chen, Sheng-Ming Wu, Yang-Hsiang Lin, et al.
Biomedicines|November 27, 2021
Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular CarcinomaKung-Hao Liang, Sung-Fang Chen, Yu-Hua Lin, et al.
American Journal of Cancer Research|July 16, 2025
Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathwayYa-Hui Huang, Chia-Jung Liao, Meng-Han Wu, et al.
Oncotarget|March 13, 2016
ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significanceI-Hsiao Chung, Hsuan Liu, Yang-Hsiang Lin, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|February 4, 2016
Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasionI-Hsiao Chung, Tzu-I Wu, Chia-Jung Liao, et al.
American Journal of Cancer Research|August 8, 2024
CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progressionHsiang-Cheng Chi, Yang-Hsiang Lin, Yuh-Harn Wu, et al.
International Journal of Molecular Sciences|June 21, 2016
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerMing-Ming Tsai, Chia-Siu Wang, Chung-Ying Tsai, et al.
International Journal of Molecular Sciences|January 21, 2023
A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular CarcinomaChih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, et al.
Cells|April 17, 2020
Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver CancerPo-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, et al.
Scientific Reports|November 3, 2017
Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214Po-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, et al.
Theranostics|June 1, 2019
Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancerChing-Ying Chen, Sheng-Ming Wu, Yang-Hsiang Lin, et al.
Biomedicines|November 27, 2021
Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular CarcinomaKung-Hao Liang, Sung-Fang Chen, Yu-Hua Lin, et al.
American Journal of Cancer Research|July 16, 2025
Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathwayYa-Hui Huang, Chia-Jung Liao, Meng-Han Wu, et al.
Oncotarget|March 13, 2016
ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significanceI-Hsiao Chung, Hsuan Liu, Yang-Hsiang Lin, et al.
Pageof 8